NCT00535639View on ClinicalTrials.gov

Tolerability of ALK Tree Tablet

PHASE1CompletedINTERVENTIONAL

Timeline

Start Date

October 31, 2007

Primary Completion Date

December 31, 2007

Conditions

Allergy

Interventions

DRUG

Betula Verrucosa allergen extract

Trial Locations (1)

2650

PhaseOne Trials, Hvidovre

All Listed Sponsors

lead

ALK-Abelló A/S

INDUSTRY

NCT00535639 - Tolerability of ALK Tree Tablet | Biotech Hunter | Biotech Hunter